查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995491

獸用整形外科植入市場：2026-2032年全球市場預測（按動物類型、植入類型、材料、應用和最終用戶分類）

Veterinary Orthopedic Implants Market by Animal Type, Implant Type, Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸用整形外科植入市場價值將達到 5.5988 億美元，到 2026 年將成長至 6.1832 億美元，到 2032 年將達到 12.6165 億美元，年複合成長率為 12.30%。

主要市場統計數據
基準年 2025 5.5988億美元
預計年份：2026年 6.1832億美元
預測年份：2032年 1,261,650,000 美元
複合年成長率 (%) 12.30%

全面概述了塑造現代獸醫整形外科植入實踐的臨床需求、技術創新和供應鏈趨勢之間的聯繫。

本導言將現代獸用整形外科植入的背景介紹給讀者，並將臨床需求、技術進步和商業性趨勢融會貫通，形成一個完整的敘述。隨著小型伴侶動物、大型家畜和某些稀有動物的臨床技術不斷進步，人們對兼具機械可靠性和生物相容性的差異化植入的需求日益成長。影像學、外科技術和術後護理的進步拓展了植入可修復的病例範圍，而材料和製造技術的同步改進則催生了新的產品配置和微創植入方法。

生物材料、積層製造和整合服務模式的進步融合如何重塑臨床預期和競爭優勢？

生物材料、製造技術和數位化工具的整合創新正在重新定義產品價值提案，並重塑產業格局。積層製造和先進影像技術帶來的個人化解決方案正在改變人們對植入物貼合度、功能和手術效率的期望。外科醫師越來越傾向於選擇能夠縮短手術時間並改善解剖結構貼合度的植入。同時，生物可吸收聚合物和陶瓷塗層技術的成熟拓展了臨時固定和表面增強骨整合的選擇範圍，使臨床醫生能夠兼顧長期生物學結果和即時機械穩定性。

對 2025 年及以後關稅調整如何重塑整個植入價值鏈的籌資策略、材料選擇和供應鏈韌性進行定性評估。

累積在2025年前後實施的關稅政策變更將對獸用整形外科植入製造商和最終用戶的採購、定價策略和供應鏈結構產生連鎖反應。進口醫用金屬和成品植入植入關稅的提高，加劇了對籌資策略的審查，促使許多機構重新審視其供應商組合，並探索替代材料採購途徑和區域生產夥伴關係。因此，採購團隊現在更加重視評估總到岸成本，並將情境規劃納入年度採購週期，以確保在維持臨床供應連續性的同時獲利。

詳細的細分分析揭示了動物類型、植入設計、材料科學、最終用戶採購和臨床應用如何影響產品策略。

細分市場層面的趨勢凸顯了臨床需求、材料科學和終端使用者行為的交會點，從而創造了差異化的機會。按動物類型分析揭示了不同類別的需求模式存在差異，包括貓狗等小型動物、牛、馬、豬等大型動物以及鳥類和爬蟲類等稀有動物。每個細分市場都有其獨特的動態和解剖學限制，這些限制會影響植入的形態、固定策略和術後通訊協定。同樣，植入類型也至關重要。鋼板和螺絲（包括動態加壓鋼板和鎖定鋼板等變體）可應對多種骨折類型，而髓內釘（中空和實心）則提供負載分散解決方案，通常是長骨固定的首選。外固定方案包括重組複雜和逐步重組的環形和單側固定類型，而互鎖釘則可在特定適應症中提供旋轉穩定性。

區域比較分析突顯了美洲、歐洲、中東、非洲和亞太市場在監管、臨床引入模式和分銷方面的複雜性和細微差異。

區域趨勢影響著法規環境、臨床醫生培訓體系和分銷網路，從而在美洲、歐洲、中東、非洲和亞太地區形成不同的策略考量。在美洲，個人執業者的高滲透率、成熟的伴侶動物照護市場以及先進的外科培訓，都促進了新型植入技術的快速普及。同時，經銷商和綜合診所集團營運商影響著採購模式和市場接受度曲線。監管路徑往往在安全性和臨床可及性之間取得平衡，為擁有可靠臨床證據的創新者創造了可預測的分銷管道。

該公司憑藉其戰略能力，透過一體化服務模式、專注的產品組合、強大的製造系統和臨床合作，推動了商業性成功。

在企業層面，發展趨勢正從產品屬性轉向更注重製造柔軟性、臨床夥伴關係以及支援部署的服務生態系統。主要企業正在投資模組化手術器械、外科培訓學院和數位化規劃平台，以降低執行風險並增加採購決策者的轉換成本。一些製造商優先考慮垂直整合的供應鏈，以確保關鍵原料供應並加快產品改進週期；而另一些製造商則尋求策略夥伴關係和契約製造，以便在無需巨額資本投資的情況下快速擴大規模。

提供可操作的、優先考慮的建議，幫助產業領導者透過數據和服務最佳化產品藍圖、加強供應鏈並加速臨床應用。

產業領導者應採取一系列切實可行的優先措施，以增強自身競爭優勢並應對不斷變化的市場壓力。首先，透過投資模組化系統和以外科醫生為中心的器械，使產品開發藍圖與臨床醫生的需求保持一致，從而減少手術時間的差異，促進臨床應用。其次，實現採購和製造地的多元化，以減輕關稅波動的影響並縮短前置作業時間。透過將特定生產線外包到近岸地區並對替代契約製造製造商進行認證，可以顯著提高抗風險能力。

採用透明、多方面的研究途徑，結合臨床醫師訪談、文獻檢驗和供應鏈分析，來檢驗對細分和情境的見解。

本研究採用結構化的多面向方法，將一手質性資料與嚴謹的二手分析結合，以確保研究結果的可靠性及其對決策者的相關性。一手研究包括對執業獸醫、採購負責人和生物醫學工程師的詳細訪談，並輔以結構化的臨床醫生問卷，以了解治療偏好和材料權衡。這些資訊與同行評審的臨床文獻、醫療設備註冊數據、監管申報文件以及公開的生產和分銷數據等二級資訊來源進行交叉比對，以檢驗趨勢並識別新的模式。

該摘要重點介紹了創新、證據生成和營運韌性如何決定獸醫整形外科植入領域的領導地位。

總之，獸用整形外科植入市場正處於轉折點，臨床創新、材料科學和營運需求在此交匯融合，形成差異化的策略路徑。優先考慮符合臨床醫生需求的設計、投資於實證醫學研究並建立靈活的生產和分銷體系的相關人員，最有可能實現永續的價值。關稅壓力凸顯了價值鏈多元化和區域化生產的重要性，而生物可吸收材料、表面技術和積層製造技術的進步正在拓展可行的臨床干預措施的範圍。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 獸用整形外科植入市場：依動物類型分類

  • 異域動物
    • 鳥類
    • 爬蟲類
  • 大型動物
    • 牛
    • 馬
    • 豬
  • 小動物
    • 貓
    • 狗

第9章 獸用整形外科植入市場：依植入類型分類

  • 外固定器
    • 戒指托
    • 單面固定裝置
  • 互鎖釘
  • 髓內釘
    • 中空釘
    • 真指甲
  • 板和螺絲
    • DCP 板
    • 鎖定鋼板

第10章 獸用整形外科植入市場：依材料類型

  • 生物可吸收聚合物
  • 陶瓷塗層
  • 防鏽的
  • 鈦

第11章 獸用整形外科植入市場：依應用領域分類

  • 骨折固定
  • 關節重組
  • 韌帶修復
  • 截骨術

第12章 獸用整形外科植入市場：依最終使用者分類

  • 門診手術中心
  • 研究和學術機構
  • 動物診所
  • 動物醫院

第13章 獸用整形外科植入市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 獸用整形外科植入市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 獸用整形外科植入市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國獸用整形外科植入市場

第17章：中國獸用整形外科植入市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BioMedtrix, Inc.
  • DePuy Synthes, Inc.
  • IMEX Veterinary Inc.
  • Kyon AG
  • Orthomed, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-FB6C9E792C19

The Veterinary Orthopedic Implants Market was valued at USD 559.88 million in 2025 and is projected to grow to USD 618.32 million in 2026, with a CAGR of 12.30%, reaching USD 1,261.65 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 559.88 million
Estimated Year [2026] USD 618.32 million
Forecast Year [2032] USD 1,261.65 million
CAGR (%) 12.30%

Comprehensive contextual overview connecting clinical demand, technological innovation, and supply chain dynamics shaping contemporary veterinary orthopedic implant practices

This introduction frames the contemporary context for veterinary orthopedic implants by connecting clinical need, technological progress, and commercial dynamics into an integrated narrative. Growing clinical sophistication across small companion animals, large livestock, and selected exotic species is driving differentiated demand for implants that combine mechanical reliability with biologic compatibility. Advances in imaging, surgical technique, and postoperative care have expanded the range of cases amenable to implant-based repair, while parallel improvements in materials and manufacturing have unlocked new product configurations and minimally invasive delivery methods.

In addition to clinical catalysts, ecosystem-level changes are reshaping procurement and deployment. Veterinary hospitals and ambulatory surgical facilities increasingly prioritize inventory rationalization and single-vendor contracting, even as academic centers and research institutes push the frontier of custom and experimental implants. These forces converge with broader supply chain considerations-raw material sourcing, regulatory compliance, and distribution channel optimization-to create a competitive landscape where clinical differentiation and operational efficiency define market leaders.

Transitioning from conventional practice patterns to a more specialized, technology-enabled model requires coordinated investment in clinician training, device validation, and end-user education. Consequently, stakeholders that align product design with clinician workflows, emphasize evidence-based performance, and demonstrate predictable logistics will achieve greater adoption and sustainable value capture.

How convergent advances in biomaterials, additive manufacturing, and integrated service models are reshaping clinical expectations and competitive advantage

The landscape is undergoing transformative shifts driven by convergent innovations in biomaterials, manufacturing, and digital tools that together redefine product value propositions. Patient-specific solutions enabled by additive manufacturing and advanced imaging are shifting expectations for fit, function, and surgical efficiency; surgeons are increasingly receptive to implants that reduce intraoperative time and improve anatomical congruence. Concurrently, the maturation of bioabsorbable polymers and ceramic-coating technologies is expanding options for temporary fixation and surface-enhanced osseointegration, prompting clinicians to weigh long-term biological outcomes alongside immediate mechanical stability.

Operationally, distribution and service models are migrating from purely transactional relationships to integrated service offerings that bundle training, instrumentation, and digital support. This shift is reinforced by a rise in cross-disciplinary collaboration between veterinary surgeons, biomedical engineers, and product developers, producing iterative refinements that translate clinical feedback into rapid design cycles. Furthermore, heightened attention to sustainability and lifecycle impacts influences material selection and manufacturing choices, nudging some manufacturers toward recyclable packaging, lean production, and regionalized supply chains to reduce lead times and carbon intensity.

Taken together, these transformative shifts are creating a market where agility in product development, demonstrated clinical outcomes, and robust post-sale support determine competitive advantage and accelerate adoption across practice settings.

Qualitative assessment of how tariff adjustments since 2025 have reshaped sourcing strategies, material choices, and supply chain resilience across the implant value chain

The cumulative impact of tariff policy changes implemented in and around 2025 has reverberated through procurement, pricing strategies, and supply chain configurations for manufacturers and end users of veterinary orthopedic implants. Tariff increases on imported medical-grade metals and finished implants have intensified scrutiny of sourcing strategies, prompting many organizations to reassess supplier portfolios and consider alternative material pathways or regional production partnerships. As a result, procurement teams have elevated total landed cost assessments and incorporated scenario planning into annual sourcing cycles to preserve margin while maintaining clinical supply continuity.

Meanwhile, some manufacturers have accelerated nearshoring and contract manufacturing diversification to mitigate exposure to import levies and shipping volatility. These adjustments often require upfront capital and revalidation of manufacturing processes, but they also create opportunities to shorten lead times and improve responsiveness to clinician demand. In parallel, distributors and hospital systems have renegotiated contractual terms, sought extended inventory agreements, and increased collaboration with manufacturers to preposition critical implant lines.

Clinically, tariff-driven cost pressures have influenced product selection dynamics; clinicians balance the benefits of premium materials such as titanium against more cost-efficient alternatives like stainless steel or emerging bioabsorbables, taking into account case complexity and long-term outcomes. In sum, the tariff environment accelerated strategic realignment across the value chain, elevating supply chain resilience, material flexibility, and regional manufacturing as enduring priorities.

In-depth segmentation analysis revealing how animal type, implant design, material science, end-user procurement, and clinical application jointly shape product strategy

Segment-level dynamics illuminate where clinical need, material science, and end-user behavior intersect to create differentiated opportunities. When analyzed by animal type, demand patterns diverge between small animals such as cats and dogs, large animals including bovine, equine, and porcine, and exotic categories exemplified by birds and reptiles; each segment imposes unique biomechanical and anatomical constraints that influence implant geometry, fixation strategy, and postoperative protocols. Similarly, implant type matters: plates and screws, with variants such as dynamic compression plates and locking plates, serve a broad range of fracture patterns, while intramedullary nails-both cannulated and solid-provide load-sharing solutions that are often preferred for long bone stabilization. External fixation options span ring and unilateral constructs that cater to complex or staged reconstructions, and interlocking nails provide rotational stability for select indications.

Material choice further differentiates product positioning with bioabsorbable polymers offering temporary support and reduced need for implant removal, ceramic coatings enhancing bone integration at the tissue-implant interface, and metals like stainless steel and titanium providing long-term structural reliability. End-user segmentation reveals distinct procurement behaviors across ambulatory surgical centers, research and academic institutes, veterinary clinics, and full-service veterinary hospitals; ambulatory centers frequently emphasize cost-efficiency and inventory turnover, academic centers prioritize innovation and evidence generation, clinics focus on workflow simplicity, and hospitals balance complexity with a need for comprehensive surgical portfolios. Finally, application-driven segmentation-fracture fixation, joint reconstruction, ligament repair, and osteotomy-maps clinical outcomes to design requirements and informs prioritization for R&D investment. Integrating these layers enables targeted product strategies that align design features with the nuanced needs of each clinical and operational context.

Comparative regional insights highlighting regulatory complexity, clinical adoption patterns, and distribution nuances across Americas, EMEA, and Asia-Pacific markets

Regional dynamics influence regulatory environments, clinician training ecosystems, and distribution networks, producing distinct strategic considerations across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong private practice penetration, a mature companion animal care market, and advanced surgical training support rapid uptake of novel implant technologies, while distributors and group-practice consolidators exert influence over purchasing patterns and adoption curves. Regulatory pathways tend to balance safety with clinical access, creating predictable channels for innovators that demonstrate robust clinical evidence.

In Europe, Middle East & Africa, heterogeneity in reimbursement structures and diverse regulatory regimes demand adaptive go-to-market approaches. Western European centers often lead in early clinical adoption and research collaboration, whereas markets in the Middle East and Africa vary widely in infrastructure and procurement sophistication, which impacts the feasibility of premium implant introductions. Across the Asia-Pacific region, a mix of high-volume public hospitals, growing private specialty clinics, and rapidly expanding veterinary services creates both scale opportunities and operational complexity. Local manufacturing capacity, especially in key Asia-Pacific hubs, can lower costs and improve responsiveness, but it also introduces competitive pressure from domestic producers that emphasize cost-value trade-offs.

Taken together, regional insights suggest that successful market entry and expansion require tailored regulatory strategies, localized clinician engagement programs, and flexible distribution models that reflect distinct payer, provider, and logistical realities.

Strategic company capabilities that drive commercial success through integrated service models, focused portfolios, and resilient manufacturing and clinical engagement

Company-level dynamics center on capabilities that extend beyond product attributes to encompass manufacturing flexibility, clinical partnerships, and service ecosystems that support adoption. Leading organizations are investing in modular instrumentation, surgeon training academies, and digital planning platforms that lower execution risk and create switching costs for procurement decision-makers. Some manufacturers emphasize vertically integrated supply chains to secure critical raw materials and to accelerate product iterations, while others pursue strategic partnerships and contract manufacturing to scale quickly without large capital expenditure.

Portfolio strategies differ: some companies prioritize breadth by offering comprehensive implant systems across multiple animal types and applications, enabling bundled purchasing relationships with hospital networks; others follow a focused playbook, concentrating on niche solutions such as bioabsorbable implants or species-specific designs to capture premium clinical share. Across the board, successful firms demonstrate disciplined post-market surveillance, publish clinical outcomes in peer-reviewed venues, and maintain active engagement with key opinion leaders to validate device performance in real-world settings. Finally, commercial excellence is increasingly defined by integrated service offerings-instrument reuse programs, sterilization logistics, and remote surgical planning support-that reduce operational friction for end users and reinforce long-term partnerships.

Actionable prioritized recommendations for industry leaders to optimize product roadmaps, fortify supply chains, and elevate clinical adoption through data and services

Industry leaders should pursue a set of pragmatic, prioritized actions to strengthen competitive position and respond to evolving market pressures. First, align product development roadmaps with clinician pain points by investing in modular systems and surgeon-centric instrumentation that reduce procedure time and variability, thereby increasing clinical uptake. Second, diversify sourcing and manufacturing footprints to reduce exposure to tariff volatility and to shorten lead times; nearshoring select production lines and qualifying alternate contract manufacturers can materially improve resilience.

Third, invest in evidence generation by supporting clinical trials and registries that demonstrate comparative outcomes across materials and implant types; robust data underpins premium pricing and facilitates payer and institutional adoption. Fourth, expand bundled service offerings that combine devices with training, digital planning, and post-sale support to create differentiated value propositions and improve customer retention. Fifth, tailor market-entry strategies to regional nuances by calibrating regulatory submissions, pricing approaches, and distribution models to local payer and provider structures. Finally, pursue selective partnerships with academic centers and specialty referral hospitals to co-develop novel solutions while leveraging those relationships to accelerate clinician education and product validation. Executed together, these actions balance short-term commercial pressures with long-term differentiation and growth potential.

Transparent multi-method research approach combining clinician interviews, literature triangulation, and supply chain analysis to validate segmentation and scenario insights

This research employs a structured, multi-method approach that integrates primary qualitative inputs with rigorous secondary analysis to ensure findings are robust and relevant to decision-makers. Primary research includes in-depth interviews with practicing veterinary surgeons, procurement professionals, and biomedical engineers, supplemented by structured clinician surveys that capture procedural preferences and material trade-offs. These inputs are triangulated against secondary sources such as peer-reviewed clinical literature, device registries, regulatory filings, and publicly available manufacturing and distribution data to validate trends and identify emergent patterns.

Methodologically, segmentation frameworks were developed to reflect real-world clinical and commercial decision levers, mapping animal type, implant design, material attributes, end-user behavior, and application to observable demand signals. Supply chain analysis focused on raw material flows, contract manufacturing relationships, and distribution channel structures to assess operational risk and time-to-market constraints. All analyses underwent internal validation through cross-functional expert review panels to test assumptions and ensure interpretive accuracy. Where appropriate, scenario analysis was used to explore the implications of tariff shocks, raw material disruptions, and accelerated adoption of new technologies, thus offering practical insight into resilience strategies and opportunity windows.

Concluding synthesis highlighting how innovation, evidence generation, and operational resilience will determine leadership in veterinary orthopedic implants

In conclusion, the veterinary orthopedic implant landscape is at an inflection point where clinical innovation, materials science, and operational exigencies intersect to create differentiated strategic pathways. Stakeholders who prioritize clinician-aligned design, invest in evidence generation, and build flexible manufacturing and distribution footprints will be best positioned to capture sustained value. Tariff-induced pressures have underscored the importance of supply chain diversification and regional manufacturing options, while advances in bioabsorbables, surface technologies, and additive manufacturing have expanded the repertoire of viable clinical interventions.

As the market evolves, success will be defined not solely by device performance but by the ability to deliver integrated solutions that reduce clinical friction, demonstrate clear outcome benefits, and adapt to regional market realities. Organizations that combine disciplined commercial execution with targeted investments in training, clinical partnerships, and post-sale services can accelerate adoption, improve patient outcomes, and secure long-term relationships with key end users. Moving forward, an evidence-driven, resilient, and service-oriented approach will separate market leaders from laggards.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Orthopedic Implants Market, by Animal Type

  • 8.1. Exotic Animals
    • 8.1.1. Birds
    • 8.1.2. Reptiles
  • 8.2. Large Animals
    • 8.2.1. Bovine
    • 8.2.2. Equine
    • 8.2.3. Porcine
  • 8.3. Small Animals
    • 8.3.1. Cats
    • 8.3.2. Dogs

9. Veterinary Orthopedic Implants Market, by Implant Type

  • 9.1. External Fixators
    • 9.1.1. Ring Fixators
    • 9.1.2. Unilateral Fixators
  • 9.2. Interlocking Nails
  • 9.3. Intramedullary Nails
    • 9.3.1. Cannulated Nails
    • 9.3.2. Solid Nails
  • 9.4. Plates And Screws
    • 9.4.1. DCP Plates
    • 9.4.2. Locking Plates

10. Veterinary Orthopedic Implants Market, by Material Type

  • 10.1. Bioabsorbable Polymers
  • 10.2. Ceramic Coatings
  • 10.3. Stainless Steel
  • 10.4. Titanium

11. Veterinary Orthopedic Implants Market, by Application

  • 11.1. Fracture Fixation
  • 11.2. Joint Reconstruction
  • 11.3. Ligament Repair
  • 11.4. Osteotomy

12. Veterinary Orthopedic Implants Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Research And Academic Institutes
  • 12.3. Veterinary Clinics
  • 12.4. Veterinary Hospitals

13. Veterinary Orthopedic Implants Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Orthopedic Implants Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Orthopedic Implants Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Veterinary Orthopedic Implants Market

17. China Veterinary Orthopedic Implants Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Arthrex, Inc.
  • 18.6. B. Braun Melsungen AG
  • 18.7. BioMedtrix, Inc.
  • 18.8. DePuy Synthes, Inc.
  • 18.9. IMEX Veterinary Inc.
  • 18.10. Kyon AG
  • 18.11. Orthomed, Inc.
  • 18.12. Smith & Nephew plc
  • 18.13. Stryker Corporation
  • 18.14. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIRDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REPTILES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RING FIXATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY UNILATERAL FIXATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTERLOCKING NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CANNULATED NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SOLID NAILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY DCP PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LOCKING PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY BIOABSORBABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY CERAMIC COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LIGAMENT REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY OSTEOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 222. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 224. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 226. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 227. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 258. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 259. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 260. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 262. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 263. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 271. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 274. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 275. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 276. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. NATO VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY PLATES AND SCREWS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXOTIC ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY LARGE ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY SMALL ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY IMPLANT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY EXTERNAL FIXATORS, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA VETERINARY ORTHOPEDIC IMPLANTS MARKET SIZE, BY INTRAMEDULLARY NAILS, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA VETERINARY O